Motilal Oswal - Bosch Limited (BOSCHLTD) MOSL: BOSCH (Neutral)-High regulatory changes augur well | BS6 translation of LoI to business critical

Report

Motilal Oswal

Jinesh Gandhi

EUR 120.00 For Business Accounts Only

MOSL: BOSCH (Neutral)-High regulatory changes augur well | BS6 translation of LoI to business critical

BOSCH: High regulatory changes augur well | BS6 translation of LoI to business critical
(BOS IN, Mkt Cap USD6.1b, CMP INR14576, TP INR14380, 1% Downside, Neutral)

We met with the management of Bosch (BOS) to understand the evolving regulatory, technological and competitive landscape in the sector. Increasing complexity due to stringent regulatory changes augur well for a technology-focused player like BOS, though the seamless translation of LoI is important for BS6 business. BOS is confident of leveraging its global knowhow at the parent level for EVs and would offer solutions from strong hybrids to BEVs.

23/10/2019 8 EN

Underlying

Bosch Limited

Co. is engaged in the manufacture and sale of fuel injection equipment, spark plugs, auto electricals, hydraulics and pneumatic equipment, portable electric power tools, lubricating oil, and spares and components.

See profile

INE323A01026 National Stock Exchange of India India

Provider

Motilal Oswal

Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance.

Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.

See profile

Analysts

Jinesh Gandhi

Other Reports on these Companies

Motilal Oswal

MOSL : BOSCH: Strong revenue growth across businesses

. BOSCH: Strong revenue growth across businesses (BOS IN, Mkt Cap USD6.4b, CMP INR17297, TP INR16150, 7% Downside, Neutral) BOS’ 1QFY23 performance was a beat on all fronts, led by strong revenue growth. With the easing of supply-chain constraints, it expects PV/LCV volumes to surpass FY18 levels. We expect this outperformance to continue on account of a revival in the CV cycle and an increase in exports, diluted by a weakness in the Tractor cycle. With a margin recovery still awaited, we see no major re-rating catalysts on the anvil. We maintain our FY23 EPS estimate, but increase our ...

EUR 120.00

August 4, 2022 August 4, 2022 EN

TheScreener

With a more favourable environment, BOSCH improves to Slightly Positive

BOSCH (IN), a company active in the Auto Parts industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date January 4, 2022, the closing price was INR 17,222.60 and its potential was estimated at INR 19,390.58.

Free Trial

January 5, 2022 January 5, 2022 6 EN

Vermilion Research

Vermilion Int'l Compass: Global Equity Strategy

MSCI ACWI Breaking To New Highs Market dynamics remain healthy and we are continuing to see signs that suggest global equities are entering a new broad-based bull market. Led by strength from the US, the MSCI ACWI index (ACWI-US) recently broke out to new highs above the important $105.40 resistance level; this is a bullish sign for global equities. Still, we are waiting for confirmation in the form of breakouts or bullish price inflections from the other broad global indexes (ACWX-US, EFA-US, and EEM-US) in order to turn bullish. Index Overview. The MSCI ACWI (ACWI-US) is breaking above the...

EUR 44.99

November 15, 2021 November 15, 2021 1 EN

MOSL : HOME FIRST FINANCE COMPANY: Earnings in-line with sustained improvement in asset quality

HOME FIRST FINANCE COMPANY: Earnings in-line with sustained improvement in asset quality (HOMEFIRS IN, Mkt Cap USD0.9b, CMP INR802, TP INR1025, 28% Upside, Buy) HomeFirst’s 2QFY23 PAT grew 21% YoY/6% QoQ to INR543m (in-line). Credit costs grew 37% QoQ to INR50m (MOFSLe: INR31m). Underlying this, the NII grew 58% YoY to ~INR1b (in-line). ‘Other income’ grew 13% QoQ, driven primarily by higher treasury gains and investment income. Opex was 7% higher than estimated and grew 47% YoY and 14% QoQ, led by investments in new branches and resultant higher employee expenses. Disbursements grew 36%...

EUR 120.00

October 21, 2022 October 21, 2022 12 EN

Aliasgar Shakir

Aliasgar Shakir

MOSL : SHOPPERS STOP: Ticking the right boxes

. SHOPPERS STOP: Ticking the right boxes (SHOP IN, Mkt Cap USD1b, CMP INR780, TP INR805, 3% Upside, Neutral) Aided by price hikes, SHOP reported a healthy 19% revenue growth in 2QFY23 from pre-COVID levels (8% beat) on healthy (+10%) SSSG and sustained volumes. EBITDA grew 2.3x YoY (22% over pre-COVID levels), with a 540bp margin improvement. 1) A strong recovery in revenue, backed by an improved pricing; 2) expansion within the Beauty and Private Label segment; and 3) healthy annual 12/15 store additions for SHOP/Beauty are expected to drive business growth going forward. We expect a r...

EUR 120.00

October 21, 2022 October 21, 2022 13 EN

Tushar Manudhane

Tushar Manudhane

MOSL : ERIS LIFESCIENCES: Enhanced efforts toward product launch-related activities

ERIS LIFESCIENCES: Enhanced efforts toward product launch-related activities (ERIS IN, Mkt Cap USD1.2b, CMP INR708, TP INR860, 21% Upside, Buy) Eris Lifesciences (ERIS) delivered better than expected 2QFY23 performance, led by superior traction in new launches and improved operating leverage. ERIS is notonly sustaining the momentum in its recently launched products, but it is also preparing itself for an aggressive pace of new introductions. We reiterate our earnings estimate for FY23/FY24 and continue to value ERIS at 22x 12M forward earnings to arrive at a price target of INR860. We re...

EUR 120.00

October 21, 2022 October 21, 2022 11 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

MOSL: BOSCH (Neutral)-High regulatory changes augur well | BS6 translation of LoI to business critical

MOSL : BOSCH: Strong revenue growth across businesses

With a more favourable environment, BOSCH improves to Slightly Positive

Vermilion Int'l Compass: Global Equity Strategy

MOSL : HOME FIRST FINANCE COMPANY: Earnings in-line with sustained improvement in asset quality

MOSL : SHOPPERS STOP: Ticking the right boxes

MOSL : ERIS LIFESCIENCES: Enhanced efforts toward product launch-related activities

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe